QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

Help viewing high resolution images Return to article

Fig. 8. Posterior Vas localization requires vls. Wild type has two copies of vas-eGFP. vls^null vls⁺, vls^PG65 and vls^null have one copy of vas-eGFP. Fixed ovaries are shown here. Live ovaries show a similar pattern although nuage signal is generally stronger than in fixed ovaries. (A-D) Stage 1-5 egg chambers, (A'-D') stage 10 egg chambers. (A,A') Wild-type localization of Vas-eGFP to nuage and to the posterior of the oocyte is observed in Sp/SM1 background. Nuage localization in vls mutants appears normal initially (C,D) and slightly reduced in stage 10 egg chambers (C',D'); however, we did not observe this reduction in live ovaries (data not shown). Posterior localization of Vas-eGFP in the oocyte is undetectable in vls^null mutants (D') and dramatically reduced in vls^PG65 hemizygotes (C'). This defect is rescued by the introduction of the vls⁺ transgene (B'). The levels of posterior Vas-eGFP appear reduced in vls^null vls⁺ oocytes, most probably because of the lower copy number of vas-eGFP. (E-H') Vas-eGFP is not detected at the posterior of young embryos from vls mutant mothers. (E-H) 0- to 1-hour-old embryos, (E'-H') 2- to 3-hour-old embryos. Vas-eGFP accumulates at the posterior of embryos (E,F) and then inside newly formed pole cells (E',F') in wild-type and vls^null vls⁺ background, but not in embryos from vls^PG65 hemizygous (G,G') and vls^null mutant (H,H') mothers.

Return to article